Adeona is developing reaZin, a product candidate for the dietary management of Alzheimer’s disease and mild cognitive impairment, as a prescription medical food. reaZin, formerly named Zinthionein, is
The trial is planned to investigate the safety and efficacy of dalbavancin to vancomycin, with patients randomized to vancomycin allowed to switch to oral linezolid after three days
Study of V-101 is a randomized, multi-centered, double-blinded, vehicle-controlled, Phase II clinical trial designed to evaluate the dose-response relationship of two concentrations of V-101 cream vs. vehicle (placebo).
The fund will also be used for completing Phase II testing of its house dust mite and grass allergy T-cell vaccines, based on its proprietary ToleroMune technology. The
The patent entitled, ‘Pharmaceutical Compositions for the Treatment of Pain,’ covers a method of treating cancer related pain by administering a combination of the cannabinoids cannabidiol (CBD) and
The new disposable filling system concept was developed in cooperation with a strategic partner for disposable materials. Using a holistic approach, flow behavior, interfaces, tubing layout, distribution and
Based on their small particle size of approximately 20 nanometers, sLNPs have the potential for broadened biodistribution beyond liver delivery. Alnylam chief scientific officer Kenneth Koblan said they
Erck, former executive chairman of the company, has been an active member of Novavax‘s senior management team for the last year and has had experience in the biotechnology
JNJ-Q2 is a Phase III-ready investigational novel fluoroquinolone antibiotic that has been shown to be effective in a Phase II study of acute bacterial and skin and skin
Through the asset purchase agreement, Forest has been assigned a license agreement between Warner Chilcott and Blue Ash, providing for worldwide rights to azimilide, and will take care
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.